Meningococcal Quadrivalent Vaccines(Nimenrix)

6 weeks or above

Nimenrix

 Provider:

PRIZER

Certification:

EMA & Hong Kong Department of Health

Suggested age:

6 weeks or above

Disease Prevention:

Meningococcal quadrivalent vaccines protect against 4 types of meningococcal bacteria: types A, C, Y and W-135.

Side Effect:

Soreness, redness and swelling where the vaccine was given.

Interval:

2, 4, 12 months old: 3 dose
3, 5, 12 months old: 3 dose
12 months old: 1 dose

Meningococcal Quadrivalent Vaccines(Nimenrix)

Precautions:

/